leadf
logo-loader
viewOptiBiotix Health PLC

OptiBiotix Health secures significant exclusive licence agreement for OptiBiome

OptiBiotix Health PLC's (LON:OPTI) Stephen O'Hara chats to Proactive's Andrew Scott after signing an exclusive licence agreement for its OptiBiome weight loss ingredient with Australian firm OptiPharm Pty Ltd.

OptiPharm owns Optislim, the number one weight management brand in Australia, which incorporates products such as shakes, soups and bars as part of total or partial meal replacements.

Quick facts: OptiBiotix Health PLC

Price: 52.1 GBX

AIM:OPTI
Market: AIM
Market Cap: £45.82 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Amryt Pharma boss 'really pleased' with FY results, on 18.5% increase in...

Amryt Pharma PLC (LON:AMYT) (NASDAQ:AMYT) CEO Joey Wiley tells Proactive it expects to continue strong sales growth for 2021 after reporting a first underlying profit and strong cash flow for the past year. Wiley says the biopharma company, which acquires, develops and commercializes novel...

2 hours, 23 minutes ago

2 min read